1.The Change of Serum Gastrin and G-cell in Gastric Antrum in Rat Model of Spleen-Qi Deficiency and the Curative Effect of Huangqi Jianzhong Decoction
Xiaowei ZHENG ; Suzhen BAO ; Ying WANG
Journal of Zhejiang Chinese Medical University 2006;0(05):-
[Objective]To explore the change of serum gastrin and G-cell in gastric antrum in rat model of spleen-qi deficiency and the curative effect of huangqi jianzhong decoction(HQJZD).[Methods]Spleen-qi deficiency syndrome was induced in rats by compound methods.After the models had been established,they were treated by different dosages of HQJZD.And at different time points,serum xylose,creatine phosphokinase,gastrin and G cells were observed.[Results]These indexes in groups of different dosages of HQJZD recovered gradually.Especially after 21 days' treatment,in groups of the middle and the high dosages,these indexes were increasing significantly when compared with those in the model control group(P
3.Progress of post-traumatic stress disorder in critical illness survivors
Jing WANG ; Mengjie BAO ; Jianning WANG ; Song ZHOU ; Ying ZENG
Chinese Journal of Practical Nursing 2017;33(19):1510-1513
In recent years, the number of ICU survivor is ever-growing with the increase of cure rate. The survivors′ outcome has aroused more and more attentions from medical personnel. ICU survivors tend to experience lasting physical, psychological and cognitive injuries, the post-traumatic stress disorder is one kind of significant psychological injury associated with patients′ critical experience. This review aims to summarize relevant literatures, introduces the prevalence, risk factors, complications, and interventions of ICU survivors′ post-traumatic stress disorder symptom, in order to prevent ICU survivors from post-ICU psychological injury and improve their long-term outcome.
6.Signif icance of expression of VEGF in lung cancer tissues and interference of Shiquan Dabu Decoction in it
Hong SONG ; Suzhen BAO ; Xiaowei ZHENG ; Ying WANG ; Yongjun ZHANG
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(08):-
Objective: To investigate the intervention of Shiquan Dabu Decoction (SQDBD) in the protein expression of VEGF. Methods: 50 C57BL/6 mice inoculated with lewis lung cancer were randomly divided into five groups and treated by different drugs. The ratio of antitumorand and antimetastatic of each group were calculated after 15 days’ treatment. The expression of VEGF was detected by SABC immunohistochemical method. Results: Low, medium and high dosages of SQDBD had the function of antitumor and antimetastusi at different extent. SQDBD could inhibit the positive expression of VEGF protein. Conclusion: Inhibition of the expression of VEGF protein is possibly one of the mechanisms of SQDBD in antitumor.
9.B/T-cell biphenotypic lymphoblastic lymphoma/leukemia: report of a case.
Ding-bao CHEN ; Ying WANG ; Lin DAI
Chinese Journal of Pathology 2013;42(10):704-705
Adult
;
Biopsy
;
CD3 Complex
;
metabolism
;
DNA Nucleotidylexotransferase
;
metabolism
;
Female
;
Humans
;
Leukemia, Biphenotypic, Acute
;
metabolism
;
pathology
;
Lymph Nodes
;
metabolism
;
pathology
;
Neck
;
PAX5 Transcription Factor
;
metabolism
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
metabolism
;
pathology
10.Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case.
Ding-bao CHEN ; Ying WANG ; Dan-hua SHEN
Chinese Journal of Pathology 2010;39(9):635-636
Aged
;
Antibodies, Monoclonal, Murine-Derived
;
therapeutic use
;
Antigens, CD20
;
metabolism
;
Antineoplastic Agents
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bleomycin
;
therapeutic use
;
CD79 Antigens
;
metabolism
;
Cyclophosphamide
;
therapeutic use
;
Dacarbazine
;
therapeutic use
;
Doxorubicin
;
therapeutic use
;
Female
;
Hodgkin Disease
;
drug therapy
;
metabolism
;
pathology
;
surgery
;
Humans
;
Lymphoma, Large B-Cell, Diffuse
;
metabolism
;
pathology
;
surgery
;
therapy
;
Neoplasms, Second Primary
;
metabolism
;
pathology
;
surgery
;
therapy
;
Prednisone
;
therapeutic use
;
Rituximab
;
Vinblastine
;
therapeutic use
;
Vincristine
;
therapeutic use